Fig. 5

The impact of Foxo3 expression on overall survival of the different groups of AML patients. a non-M3 patients. b Normal Karyotypic patients. c Non-Favorable patients. Survival analysis was performed via Kaplan–Meier survival analysis, with differences between curves analyzed via a log-rank test. Significance was defined as P < 0. 05